Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02715622 · ClinicalTrials.gov registry record
A Prospective Study to Compare the Clinical Outcomes, Pain and Patient Quality of Life for Hernia Patients
A clinical trial of Inguinal Hernia and Hernia, sponsored by Intuitive Surgical.
- Completed
- Registry status
- 944
- Enrollment target
- 17
- Study locations
NCT02715622: Completed study of Inguinal Hernia and Hernia, sponsored by Intuitive Surgical.
NCT02715622 is a study of Inguinal Hernia and Hernia that has completed, run by Intuitive Surgical. The registered enrollment target is 944 participants, above the 271-participant average among 11 other Inguinal Hernia trials with a reported enrollment target (248% higher). The trial reports 17 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02715622, a study of Inguinal Hernia and Hernia, has completed, sponsored by Intuitive Surgical.
- COMPLETED
- Registry status
- 944 participants
- Enrollment target
- 17
- Study locations
Study Summary
The objective of this prospective, multi-center post-market study is to prospectively collect uniform, evidence based outcomes for patients undergoing open, laparoscopic or robotic assisted hernia repair. The outcomes that will be collected include various routine clinical parameters, short term patient reported outcomes (quality of life, pain scores) and long term hernia recurrence information. Patients will be treated according to standard of care at the surgeon's institution and patients will be followed up to collect information related to complications information and patient satisfaction associated with the hernia repair procedure.
Primary Outcome
Number of intraoperative and short-term complications related to hernia repair.
Conditions Studied
Interventions
- PROCEDURE Hernia repair
Study Locations (17)
California
- Beverly Hills Hernia Center - Beverly Hills
- Vanderbilt University Medical Center - Nashville
- Kaiser Foundation Research Institute - Oakland
Illinois
- Southern Illinois Healthcare - Carbondale
- Rush University Medical Center - Chicago
- Progressive Surgical Associates - New Lenox
Florida
- Florida Hospital - Celebration Health - Celebration
- Baptist Health South Florida - South Miami
Kentucky
- Louisville Surgical Associates - Louisville
Louisiana
- Our Lady of the Lake Regional Medical Center - Baton Rouge
Maryland
- Mercy Medical Center - Baltimore
Michigan
- Spectrum Health System - Grand Rapids
New York
- The Mount Sinai Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 944 participants |
| Start Date | 2016-04 |
| Est. Completion | 2022-10 |
What the finished NCT02715622 record still lists
NCT02715622 is an observational study that tracks outcomes without assigning an intervention. The registered 944 participants enrollment target is mid-sized for trials with a published cap, above the 271-participant average among 11 other Inguinal Hernia trials with a reported enrollment target (248% higher).
The record links to 5 conditions, with Inguinal Hernia appearing as the primary indexed condition, and to 1 intervention - of which Hernia repair is the first listed.
NCT02715622 lists 17 locations in 12 states (California, Illinois, Florida).
Frequently Asked Questions
What is clinical trial NCT02715622 about?
NCT02715622 is a clinical study titled "A Prospective Study to Compare the Clinical Outcomes, Pain and Patient Quality of Life for Hernia Patients". The objective of this prospective, multi-center post-market study is to prospectively collect uniform, evidence based outcomes for patients undergoing open, laparoscopic or robotic assisted hernia repair. The outcomes that will be collected include various routine clinical parameters, short term pa...
What is the current status of trial NCT02715622?
This trial is currently completed. The enrollment target is 944 participants. The study started on 2016-04. Estimated completion is 2022-10.
What conditions does trial NCT02715622 study?
This clinical trial studies the following conditions: Inguinal Hernia, Hernia, Incisional Hernia, Hernia, Inguinal, Indirect, Hernia, Inguinal, Direct.
What interventions are being tested in trial NCT02715622?
The interventions under investigation include: Hernia repair (PROCEDURE).
Who is sponsoring clinical trial NCT02715622?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02715622 being conducted?
This trial has 17 study locations across California, Florida, Illinois, Kentucky, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inguinal Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02715622's enrollment target sits among peer trials
944 1st of 11 higher than 11 of 11 other Inguinal Hernia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inguinal Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Pilot Study of Local Anesthesia for Inguinal Hernia Surgery in Older Adults
RECRUITING · NA
-
Activity Restrictions After Inguinal Hernia Repair
RECRUITING · NA
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs
ACTIVE NOT RECRUITING · Early Phase 1
-
No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair
ACTIVE NOT RECRUITING · Phase 4
-
Treatment of Occult Inguinal Hernias
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05020236 · 944 participants · Phase 3
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- NCT06808334 · 942 participants
CLAiR Pivotal Study
- NCT07190209 · 942 participants · Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- NCT07190222 · 942 participants · Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia